(E)-3-(2-ethyl-pyridin-4-yl)-acrylonitrile → 7-(2-Ethyl-pyridin-4-yl)-2-pyridin-2-yl-[1,2,4]triazolo[1,5-a]pyridin-5-ylamine
Reaction equation
C1(S([CH2:10][C:11]2[N:12]=[C:13]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][N:17]=3)[NH:14][N:15]=2)(=O)=O)C=CC=CC=1.[CH2:22]([C:24]1[CH:29]=[C:28](/[CH:30]=[CH:31]/[C:32]#[N:33])[CH:27]=[CH:26][N:25]=1)[CH3:23]>>[CH2:22]([C:24]1[CH:29]=[C:28]([C:30]2[CH:31]=[C:32]([NH2:33])[N:15]3[N:14]=[C:13]([C:16]4[CH:21]=[CH:20][CH:19]=[CH:18][N:17]=4)[N:12]=[C:11]3[CH:10]=2)[CH:27]=[CH:26][N:25]=1)[CH3:23]Participants
3
Procedure
The title compound, MS m/e (%):316(M+,100), was prepared in accordance with the general method of example 1 from 2-(5-benzenesulfonylmethyl-2H-[1,2,4]triazol-3-yl)-pyridine and (E)-3-(2-ethyl-pyridin-4-yl)-acrylonitrile.
Sources & evidence
- ORD record
- ord-99d0449b4fcb480db86f404920e3b830
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06355653B1
Reaction notes
Loading…